November 29, 2016
 
eSequence
FUND CANCER RESEARCH THAT SAVES LIVES

Good morning - and welcome to  #GivingTuesday.
 
Today is the day when a movement of nonprofit organizations, local businesses and philanthropists in the U.S. come together to promote and participate in a national giving day.
 
You're going to hear and read a lot from our fellow nonprofits, but it's our hope that you will support ACGT and help us in our battle against cancer.
 
One in four Americans will develop cancer in their lifetime. With your support, we will continue to accelerate groundbreaking research in brain cancer, osteosarcoma and blood cancers using techniques like immunotherapy, oncolytic viruses and CRISPR. Patients in ACGT-funded clinical trials who once had no other options are going into remission - help us make this dream a reality for all cancer patients. 100% of your donation will be used to support ACGT research grants and studies in cell and gene therapies for cancer.
 
Our work together-not just your day-is just getting started. Thank you for your support.  
 
ACGT is the only non-profit organization in the nation dedicated exclusively to funding  cell and gene therapies for cancer. Since its founding in 2001, ACGT has awarded  50 gr ants totaling over $26 million in North America, and continues to be a catalyst for cell and gene therapy research.
 
100% of all donations are used to support ACGT research grants and studies in cell and gene therapies for cancer.

Share our hope and share our dedication to more effective ways of targeting cancer .
Please forward this email to anyone whose life has been touched by cancer. 
 
Keep posted on progress at www.acgtfoundation.org, on Facebook and Twitter.